BMI View: Egypt’s evolving demographic and epidemiological profile will support pharmaceutical growth
over the long-term. The Egyptian government’s commitment to healthcare has been demonstrated through
significant increases to national budget allocations for the health sector. We note that the government is
demonstrating increasing will to implement policy reforms within the health sector, boosting Egypt’s
attractiveness to international pharmaceutical companies. However, questions regarding financial
feasibility will be raised. The country’s improving political outlook and gradual economic recovery, albeit a
slow one, will add to the market’s attractiveness; however, regional instabilities remain a deterrent to
company interest.
Headline Expenditure Projections
? Pharmaceuticals: EGP33.08bn (USD4.29bn) in 2015 to EGP36.48bn (USD4.47bn) in 2016; +10.3% in
local currency terms and 4.1% in US dollar terms. Forecast unchanged from Q116
? Healthcare: EGP114.20bn (USD14.83bn) in 2015 to EGP127.06bn (USD15.57bn) in 2016; +11.3% in
local currency terms and 5.0% in US dollar terms. Forecast upgraded from Q116.

Table of Contents

BMI Industry View 7
Table: Headline Pharmaceuticals & Healthcare Forecasts (Egypt 2014-2020) 7
SWOT 9
Industry Forecast 11
Pharmaceutical Market Forecast 11
Table: Pharmaceutical Sales, Historical Data And Forecasts (Egypt 2012-2020) 13
Healthcare Market Forecast 14
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Egypt 2012-2020) 16
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Egypt 2012-2020) 17
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Egypt 2012-2020) . 17
Prescription Drug Market Forecast 18
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Egypt 2012-2020) 19
Patented Drug Market Forecast 20
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Egypt 2012-2020) 21
Generic Drug Market Forecast 22
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Egypt 2012-2020) 24
OTC Market Forecast 25
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Egypt 2012-2020) 27
Pharmaceutical Trade Forecast 28
Table: Pharmaceutical Trade Data And Forecasts (Egypt 2014-2020) 30
Table: Pharmaceutical Trade Data And Forecasts local currency (Egypt 2014-2020) 31
Industry Risk Reward Index 32
Middle East and Africa Risk/Reward Index - Q2 2016 32
Egypt Risk/Reward Index 39
Rewards 39
Risks 40
Regulatory Review 41
Intellectual Property Issues 41
Pricing Regime 43
Reimbursement Regime 45
Market Overview 48
Healthcare Sector 49
Table: Healthcare Resources (Egypt 2010-2015) 53
Table: Healthcare Personnel (Egypt 2010-2015) 53
Table: Healthcare Activity (Egypt 2010-2015) 54
Research & Development 54
Clinical Trials 55
Epidemiology 56
Competitive Landscape 61
Research-Based Industry 61
Table: Multinational Market Activity 63
Generic Drugmakers 64
Pharmaceutical Distribution 65
Pharmaceutical Retail Sector 65
Company Profile 67
Amoun Pharmaceutical Company (APC) 67
Egyptian International Pharmaceutical Industries Co (EIPICO) 70
Medical Union Pharmaceuticals (MUP) 74
South Egyptian Drug Industries (SEDICO) 77
VACSERA 80
Demographic Forecast 82
Demographic Outlook 82
Table: Population Headline Indicators (Egypt 1990-2025) 83
Table: Key Population Ratios (Egypt 1990-2025) 83
Table: Urban/Rural Population & Life Expectancy (Egypt 1990-2025) 84
Table: Population By Age Group (Egypt 1990-2025) 84
Table: Population By Age Group % (Egypt 1990-2025) 85
Glossary 87
Methodology 89
Pharmaceutical Expenditure Forecast Model 89
Healthcare Expenditure Forecast Model 89
Notes On Methodology 90
Risk/Reward Index Methodology 91
Index Overview 92
Table: Pharmaceutical Risk/Reward Index Indicators 92
Indicator Weightings 93

List of Tables

Table: Headline Pharmaceuticals & Healthcare Forecasts (Egypt 2014-2020)
Table: Pharmaceutical Sales, Historical Data And Forecasts (Egypt 2012-2020)
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Egypt 2012-2020)
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Egypt 2012-2020)
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Egypt 2012-2020)
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Egypt 2012-2020)
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Egypt 2012-2020)
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Egypt 2012-2020)
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Egypt 2012-2020)
Table: Pharmaceutical Trade Data And Forecasts (Egypt 2014-2020)
Table: Pharmaceutical Trade Data And Forecasts local currency (Egypt 2014-2020)
Table: Healthcare Resources (Egypt 2010-2015)
Table: Healthcare Personnel (Egypt 2010-2015)
Table: Healthcare Activity (Egypt 2010-2015)
Table: Multinational Market Activity
Table: Population Headline Indicators (Egypt 1990-2025)
Table: Key Population Ratios (Egypt 1990-2025)
Table: Urban/Rural Population & Life Expectancy (Egypt 1990-2025)
Table: Population By Age Group (Egypt 1990-2025)
Table: Population By Age Group % (Egypt 1990-2025)
Table: Pharmaceutical Risk/Reward Index Indicators